SYK vs. ABT, ISRG, BSX, MDT, BDX, EW, DXCM, IDXX, RMD, and STE
Should you be buying Stryker stock or one of its competitors? The main competitors of Stryker include Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Boston Scientific (BSX), Medtronic (MDT), Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), DexCom (DXCM), IDEXX Laboratories (IDXX), ResMed (RMD), and STERIS (STE). These companies are all part of the "health care equipment" industry.
Abbott Laboratories (NYSE:ABT) and Stryker (NYSE:SYK) are both large-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, risk, analyst recommendations, earnings, dividends, media sentiment, community ranking, profitability and institutional ownership.
Abbott Laboratories received 29 more outperform votes than Stryker when rated by MarketBeat users. Likewise, 69.62% of users gave Abbott Laboratories an outperform vote while only 64.54% of users gave Stryker an outperform vote.
In the previous week, Abbott Laboratories had 1 more articles in the media than Stryker. MarketBeat recorded 19 mentions for Abbott Laboratories and 18 mentions for Stryker. Abbott Laboratories' average media sentiment score of 0.70 beat Stryker's score of 0.61 indicating that Stryker is being referred to more favorably in the news media.
75.2% of Abbott Laboratories shares are held by institutional investors. Comparatively, 77.1% of Stryker shares are held by institutional investors. 0.5% of Abbott Laboratories shares are held by insiders. Comparatively, 5.9% of Stryker shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Abbott Laboratories has a beta of 0.76, indicating that its stock price is 24% less volatile than the S&P 500. Comparatively, Stryker has a beta of 0.91, indicating that its stock price is 9% less volatile than the S&P 500.
Stryker has a net margin of 16.03% compared to Stryker's net margin of 13.96%. Abbott Laboratories' return on equity of 23.05% beat Stryker's return on equity.
Abbott Laboratories has higher revenue and earnings than Stryker. Abbott Laboratories is trading at a lower price-to-earnings ratio than Stryker, indicating that it is currently the more affordable of the two stocks.
Abbott Laboratories pays an annual dividend of $2.20 per share and has a dividend yield of 2.2%. Stryker pays an annual dividend of $3.20 per share and has a dividend yield of 0.9%. Abbott Laboratories pays out 68.5% of its earnings in the form of a dividend. Stryker pays out 36.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Abbott Laboratories has increased its dividend for 53 consecutive years and Stryker has increased its dividend for 31 consecutive years. Abbott Laboratories is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.
Abbott Laboratories currently has a consensus price target of $120.60, indicating a potential upside of 19.71%. Stryker has a consensus price target of $370.50, indicating a potential upside of 8.62%. Given Stryker's higher possible upside, analysts clearly believe Abbott Laboratories is more favorable than Stryker.
Summary
Stryker beats Abbott Laboratories on 13 of the 21 factors compared between the two stocks.
Get Stryker News Delivered to You Automatically
Sign up to receive the latest news and ratings for SYK and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SYK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
